Journal Article10.3200/AEPR.105.4.37-39
O Brave New World
44
About: This article is published in Arts Education Policy Review. The article was published on 01 Mar 2004.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future
TL;DR: The therapeutic modulation of TNF now moves into the era of personalized medicine with society's challenging expectations of durable treatment success and of achieving long-term disease remission.
746
Clinical trial development for biosimilars.
Rieke Alten,Bruce N. Cronstein +1 more
TL;DR: Clinical trials aim to resolve uncertainties that may remain following nonclinical development regarding the similarity of the proposed biosimilar with the reference product and serve to inform phase 3 clinical development.
83
Advances in the treatment of rheumatoid arthritis.
TL;DR: Recently, the approval of the first small molecule targeting intracellular pathways has opened a new chapter in the treatment of rheumatoid arthritis and other emerging treatment strategies include the activation of regulatory T cells as well as new cytokine-targeting therapies.
69
Key considerations in the preclinical development of biosimilars.
Lynne A. Bui,Susan Hurst,Gregory L. Finch,Beverly Ingram,Ira Jacobs,Carol F. Kirchhoff,Chee-Keng Ng,Anne M. Ryan +7 more
TL;DR: The aim of this article is to increase understanding of the preclinical development and evaluation process for biosimilar, as required by the regulatory agencies, that precedes the clinical testing of biosimilars in humans.
64
Biosimilars to treat inflammatory arthritis: the challenge of proving identity
Jonathan Kay,Josef S Smolen +1 more
TL;DR: The results of the first randomised, prospective clinical trials comparing a biosimilar to an original (or ‘innovator’) biopharmaceutical for a rheumatic disease indication, are published.
57
References
•Book
The Society of the Spectacle
Guy Debord
- 01 Jan 1967
TL;DR: The Society of the Spectacle as mentioned in this paper is one of the most influential theoretical works for a wide range of political and revolutionary practice in the 1960s, and it has been widely used in the literature since.